US FDA draft proposals for companion diagnostics signals simultaneous drug/IVD review
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued for stakeholder comment draft guidance on its policy on reviewing companion diagnostics, ie tests that are used to tailor drug therapies to patients1,2.